Back to Search
Start Over
Exploring discordant data in dementia clinical trials.
- Source :
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association; Dec2021 Supplement S9, Vol. 17, p1-1, 1p
- Publication Year :
- 2021
-
Abstract
- Background: We have observed numerous apparent inconsistencies in direction of scale (eg – MMSE, ADAS‐Cog and CDR) change between visits across multiple dementia clinical trials. While all instruments are not expected to move in the same direction, clinically meaningful changes in opposite directions may signal scoring and/or administration errors in one or more scales. In this analysis, we explore a) the extent to which such discordances between the MMSE, ADAS‐Cog and CDR occur in dementia clinical trials, and b) whether any associations between the presence of such discordances and scoring and/or administration errors exist. Method: Blinded data were obtained from multi‐national dementia clinical trials in early AD. Visit‐to‐visit point change was calculated for the MMSE, ADAS‐Cog and CDR‐sb. Clinically meaningful changes were defined as ≥ 4 points for the ADAS‐Cog, 3 points for the MMSE and 1 point for the CDR‐sb. We defined discordance occurring when at least 2 of 3 instruments showed clinically meaningful change, but in opposite directions. We also evaluated data from the corresponding Endpoint Quality reviews of both the worksheet and audio recordings of these assessments. These were performed by calibrated, independent Clinicians and assessed whether there were any administration and/or scoring errors. Descriptive statistics and logistic regression analyses were used to address our questions. Result: Data were collected from 4,892 randomized subjects. Visit‐to‐visit discordances were identified in 1,732 out of 15,321(11.30%) collected visits. Discordances were significantly less likely at baseline than after randomization (OR=0.54; CI=0.49‐0.61). The presence of baseline discordances significantly increased the odds of post‐baseline discordances (OR = 1.7; CI=1.4‐2.1). No association between the presence of discordances and administration or scoring errors was identified. Conclusion: We have identified over 11% of study visits affected by clinically meaningful discordances between the visit‐to‐visit changes between the MMSE, ADAS‐cog and CDR‐SB. Despite the expected lower presence of baseline than post‐baseline discordances, discordances at baseline affected over 8% of randomized subjects. The lack of association between the discordances and administration or scoring errors is surprising and we plan further analyses to understand this phenomenon better. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 15525260
- Volume :
- 17
- Database :
- Supplemental Index
- Journal :
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association
- Publication Type :
- Academic Journal
- Accession number :
- 154461959
- Full Text :
- https://doi.org/10.1002/alz.053623